SU 6668
|
- $5 - $1350
- Product name: SU 6668
- CAS: 210644-62-5
- MF: C18H18N2O3
- MW: 310.35
- EINECS:
- MDL Number:MFCD09743433
- Synonyms:SU 6668;3-(2,4-Dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)-propionic acid;1H-Pyrrole-3-propanoic acid, 5-((Z)-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-;5-((Z)-1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid;PDGFR Tyrosine Kinase Inhibitor VI, SU6668;3-[2,4-dimethyl-5-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoicacid;PDGFR Tyrosine Kinase Inhibitor VI, SU6668 - CAS 210644-62-5 - Calbiochem;3-(2,4-Dimethyl-5-{[(3Z)-2-oxo-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid
29 prices
Selected condition:
Brand
- Ambeed
- AvaChem
- Axon Medchem
- Chemenu
- ChemScene
- Crysdot
- CSNpharm
- Matrix Scientific
- Sigma-Aldrich
- Tocris
- TRC
- Usbiological
Package
- 5mg
- 10mg
- 25mg
- 50mg
- 10
- 100mg
- 250mg
- 250.00mg
- 1.00g
- 1g
- 5g
- ManufacturerAmbeed
- Product numberA146183
- Product descriptionSU6668 97%
- Packaging25mg
- Price$5
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA146183
- Product descriptionSU6668 97%
- Packaging5g
- Price$405
- Updated2021-12-16
- Buy
- ManufacturerAvaChem
- Product number4723
- Product descriptionOrantinib; SU-6668 97%
- Packaging1g
- Price$690
- Updated2026-05-22
- Buy
- ManufacturerAvaChem
- Product number4723
- Product descriptionOrantinib; SU-6668 97%
- Packaging5mg
- Price$59
- Updated2026-05-22
- Buy
- ManufacturerAvaChem
- Product number4723
- Product descriptionOrantinib; SU-6668 97%
- Packaging10mg
- Price$79
- Updated2026-05-22
- Buy
- ManufacturerAvaChem
- Product number4723
- Product descriptionOrantinib; SU-6668 97%
- Packaging25mg
- Price$129
- Updated2026-05-22
- Buy
- ManufacturerAvaChem
- Product number4723
- Product descriptionOrantinib; SU-6668 97%
- Packaging100mg
- Price$239
- Updated2026-05-22
- Buy
- ManufacturerAxon Medchem
- Product numberAxon1891
- Product descriptionSU 6668
- Packaging50mg
- Price$363
- Updated2026-05-19
- Buy
- ManufacturerAxon Medchem
- Product numberAxon1891
- Product descriptionSU 6668
- Packaging10mg
- Price$110
- Updated2026-05-19
- Buy
- ManufacturerChemenu
- Product numberCM147636
- Product description(Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)-methyl)-1H-pyrrol-3-yl)propanoic acid 95%+
- Packaging5g
- Price$292
- Updated2026-05-20
- Buy
- ManufacturerChemenu
- Product numberCM147636
- Product description(Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)-methyl)-1H-pyrrol-3-yl)propanoic acid 95%+
- Packaging5g
- Price$292
- Updated2026-05-26
- Buy
- ManufacturerChemenu
- Product numberCM147636
- Product description(Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)-methyl)-1H-pyrrol-3-yl)propanoicacid 95%+
- Packaging1g
- Price$491
- Updated2021-12-16
- Buy
- ManufacturerChemScene
- Product numberCS-0102969
- Product description(Z)-Orantinib 99.02%
- Packaging50mg
- Price$432
- Updated2021-12-16
- Buy
- ManufacturerChemScene
- Product numberCS-0102969
- Product description(Z)-Orantinib 99.02%
- Packaging100mg
- Price$756
- Updated2021-12-16
- Buy
- ManufacturerChemScene
- Product numberCS-0102969
- Product description(Z)-Orantinib 99.02%
- Packaging10mg
- Price$108
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11166850
- Product descriptionSU6668 97%
- Packaging250mg
- Price$218
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Ambeed | A146183 | SU6668 97% | 25mg | $5 | 2021-12-16 | Buy |
| Ambeed | A146183 | SU6668 97% | 5g | $405 | 2021-12-16 | Buy |
| AvaChem | 4723 | Orantinib; SU-6668 97% | 1g | $690 | 2026-05-22 | Buy |
| AvaChem | 4723 | Orantinib; SU-6668 97% | 5mg | $59 | 2026-05-22 | Buy |
| AvaChem | 4723 | Orantinib; SU-6668 97% | 10mg | $79 | 2026-05-22 | Buy |
| AvaChem | 4723 | Orantinib; SU-6668 97% | 25mg | $129 | 2026-05-22 | Buy |
| AvaChem | 4723 | Orantinib; SU-6668 97% | 100mg | $239 | 2026-05-22 | Buy |
| Axon Medchem | Axon1891 | SU 6668 | 50mg | $363 | 2026-05-19 | Buy |
| Axon Medchem | Axon1891 | SU 6668 | 10mg | $110 | 2026-05-19 | Buy |
| Chemenu | CM147636 | (Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)-methyl)-1H-pyrrol-3-yl)propanoic acid 95%+ | 5g | $292 | 2026-05-20 | Buy |
| Chemenu | CM147636 | (Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)-methyl)-1H-pyrrol-3-yl)propanoic acid 95%+ | 5g | $292 | 2026-05-26 | Buy |
| Chemenu | CM147636 | (Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)-methyl)-1H-pyrrol-3-yl)propanoicacid 95%+ | 1g | $491 | 2021-12-16 | Buy |
| ChemScene | CS-0102969 | (Z)-Orantinib 99.02% | 50mg | $432 | 2021-12-16 | Buy |
| ChemScene | CS-0102969 | (Z)-Orantinib 99.02% | 100mg | $756 | 2021-12-16 | Buy |
| ChemScene | CS-0102969 | (Z)-Orantinib 99.02% | 10mg | $108 | 2021-12-16 | Buy |
| Crysdot | CD11166850 | SU6668 97% | 250mg | $218 | 2021-12-16 | Buy |
Properties
storage temp. :+2C to +8C
solubility :DMSO : 50 mg/mL (161.11 mM; Need ultrasonic)
form :Dark yellow solid
color :Orange to red
InChI :1S/C18H18N2O3/c1-10-12(7-8-17(21)22)11(2)19-16(10)9-14-13-5-3-4-6-15(13)20-18(14)23/h3-6,9,19H,7-8H2,1-2H3,(H,20,23)(H,21,22)/b14-9-
InChIKey :NHFDRBXTEDBWCZ-ZROIWOOFSA-N
SMILES :CC1=C(C(C)=C(/C=C2C(NC3=CC=CC=C\23)=O)N1)CCC(O)=O
solubility :DMSO : 50 mg/mL (161.11 mM; Need ultrasonic)
form :Dark yellow solid
color :Orange to red
InChI :1S/C18H18N2O3/c1-10-12(7-8-17(21)22)11(2)19-16(10)9-14-13-5-3-4-6-15(13)20-18(14)23/h3-6,9,19H,7-8H2,1-2H3,(H,20,23)(H,21,22)/b14-9-
InChIKey :NHFDRBXTEDBWCZ-ZROIWOOFSA-N
SMILES :CC1=C(C(C)=C(/C=C2C(NC3=CC=CC=C\23)=O)N1)CCC(O)=O
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
Description
PDGFR Tyrosine Kinase Inhibitor VI, SU6668 is a cell-permeable indolinone compound that acts as a potent ATP-competitive inhibitor against RTKs (receptor tyrosine kinases) Kit, PDGFRβ, VEGFR2 (Flk-1/KDR), FGFR1 activity in vitro (IC50 = 0.01, 0.1, 3.9, and 3.8 M, respectively) and PDGF/VEGF/bFGF-mediated angiogenesis and tumor development. Although initially characterized as an RTK inhibitor, SU6668 is now also known to target ser/thr kinases Aurora A, Aurora B, TBK1 (NAK/T2K), and AMPK (IC50 = 0.85, 0.047, 1.4, and 1.8 M, respectively), as well as non-receptor TKs Lyn and Yes (IC50 = 4.3 and 5.8 M, respectively).More related product prices
405169-16-6 ARRY-334543 Momelotinib CO-1686 PLX3397 (Pexidartinib) CAL-101 Lestaurtinib Masitinib (AB1010) Decernotinib GPLG0634 X-376 905854-02-6 INCB39110Related product price
- 405169-16-6
$55-6121.5 - ARRY-334543
$44-2700 - Momelotinib
$30-1500
Suppliers and manufacturers
Baoji Guokang Healthchem co.,ltd
Zibo Hangyu Biotechnology Development Co., Ltd
Aladdin Scientific
Hebei Fanbo Pharmaceutical Technology Co., Ltd
Shenzhen Nexcon Pharmatechs Ltd.
NANJING YINGWEN BIOTECHNOLOGY CO LTD
Nanjing Moldeep Biochemical Co., Ltd.
Amadis Chemical Company Limited
Shanghai Boyle Chemical Co., Ltd.




